Autres langues Capstone Holding Corp.

Actions

CAPS

US14068E2081

Marché Fermé - OTC Markets Autres places de cotation 17:28:02 10/05/2024			Varia. 5j.	Varia. 1 janv.
4,625 ^USD	-7,50%		0,00%	-11,06%

01/04	Capstone Holding Corp. publie ses résultats pour l'exercice clos le 31 décembre 2023	CI
2023	Capstone Holding Corp. annonce un changement au sein de son conseil d'administration	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Capstone Holding Corp. Announces Change in Board of Directors	29/12
Capstone Holding Corp. Announces CFO Change	28/08/23
Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Capstone Therapeutics : Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder, BP Peptides, LLC	21/06/22
Capstone Therapeutics Corp. announced that it has received $1.498 million in funding	06/04/21
Capstone Therapeutics Corp. acquired an unknown stake Instone Co.	01/04/20
CAPSTONE THERAPEUTICS ANNOUNCES TRANSACTION WITH TOTALSTONE LLC	28/03/20
Capstone Therapeutics Corp. entered into an agreement to acquire an unknown stake in Instone Co.	27/03/20
Capstone Therapeutics Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019	13/08/19
Capstone Therapeutics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019	13/05/19
Capstone Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	22/03/19
Capstone Therapeutics Corp. Announces Executive Appointments	17/07/17
Capstone Therapeutics Corp. announced that it expects to receive $1.01 million in funding	14/07/17
Capstone Therapeutics Corp. Announces Resignation of Eric W. Fangmann from the Board of Directors and Audit Committee	18/03/16
Capstone Therapeutics Corp. announced that it has received $1 million in funding from BVF Partners LP	03/02/16
Capstone Therapeutics Corp. announced that it expects to receive $1 million in funding from BVF Partners LP	11/12/15
Capstone Therapeutics Corp. and LipimetiX Development, Inc. Announce Patent Application for Novel, More Potent Chimeric Apo E Mimetic Peptides	23/07/15
Capstone Therapeutics Qualifies Fangmann to Serve on the Company’s Board	08/05/15
Capstone Therapeutics Corp. Auditor Raises 'Going Concern' Doubt	16/03/15

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Capstone Holding Corp.

Actions

CAPS

US14068E2081

Autres langues

Filtres